Vivos Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Vivos Therapeutics, Inc. (VVOS) had Deferred Tax Assets, Operating Loss Carryforwards of $21.97 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.97M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.60M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $19.87M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.35M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $13.79M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $21.97M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $17.60M 10-K · filed 2026-04-15 | $19.87M 10-K · filed 2025-03-31 |
| 2023-12-31 | $17.35M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $13.79M 10-K/A · filed 2024-07-30 | |
| 2021-12-31 | $9.15M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $5.11M 10-K · filed 2022-03-31 | $5.11M 10-K · filed 2021-03-25 |
| 2019-12-31 | $4.37M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |